Risk Factors for Pregnancy-induced Hypertension in Pregnant Patients Undergoing Cesarean Section: a Retrospective Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Adverse Maternal and Neonatal Outcomes
- Sponsor
- RenJi Hospital
- Enrollment
- 1200
- Locations
- 1
- Primary Endpoint
- Adverse maternal outcomes
- Last Updated
- 5 years ago
Overview
Brief Summary
After Institutional Review Board approval, we performed a retrospective cohort study among all women presenting for pregnancy-induced hypertension under Cesarean section in Renji Hospital Affiliated to Shanghai Jiaotong University from January 2013 to January 2020.Perioperative data were collected, including preoperative general condition, laboratory examination, auxiliary examination (blood routine, blood coagulation, liver and kidney function, electrocardiogram, cardiac ultrasound, etc.), perioperative indicators, postoperative laboratory examination (blood routine, blood coagulation, liver and kidney function, etc.), postoperative follow-up and satisfaction survey of patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •all women presenting for pregnancy-induced hypertension in Renji Hospital Affiliated to Shanghai Jiaotong University from January 2013 to January 2020 cesarean section operation
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Adverse maternal outcomes
Time Frame: 42 days after delivery
Adverse maternal outcomes were evaluated individually and as a composite and included number of acute kidney injury (serum creatinine \>1.1 mg/dL or oliguria), number of blood transfusion, number of eclampsia, rate of intensive care unit (ICU) admission, number of postpartum hemorrhage, or pulmonary edema.(From date of randomization until the date of discharged from hospital, whichever came first, assessed up to 40 weeks").
Adverse neonatal outcomes
Time Frame: 42 days after delivery
Number of neonatal outcomes included preterm birth (PTB; \<37 weeks), Number of neonatal ICU (NICU) admission, number of neonatal intubation, and number of respiratory distress syndrome.（From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 40weeks）.(From the date of birth until the date of discharged from hospital, whichever came first, assessed up to 5 weeks").